Avid Bioservices Inc (NAS:CDMO)
$ 7.54 0.73 (10.72%) Market Cap: 478.64 Mil Enterprise Value: 642.83 Mil PE Ratio: 0 PB Ratio: 2.66 GF Score: 73/100

Avid Bioservices Inc at RBC Capital Markets Virtual Pharmaceutical CDMO Conference Transcript

Oct 03, 2022 / 04:15PM GMT
Release Date Price: $17.53 (-8.32%)
Sean Wilfred Dodge
RBC Capital Markets, Research Division - Analyst

Thanks, everybody, for joining us, and welcome to the last session of the day of RBC's inaugural virtual CDMO Conference. My name is Sean Dodge. I'm the pharma services HCIT analyst here at RBC. And I'm pleased to be joined by Nick Green, who is the CEO of our next presenting company, Avid Bioservices.

Questions & Answers

Sean Wilfred Dodge
RBC Capital Markets, Research Division - Analyst

So Nick, thank you for sharing your time with us. We'll -- I guess where I'd like to start is, is we do have a bit of a diverse audience here with I think some people are probably a little bit newer to the story. So if you want to just set the scene for us and give us a little bit of background on how Avid got started and what changed. There's been a lot of change in the last few years. What changed? And then maybe where we're at now?

Nicholas Stewart Green
Avid Bioservices, Inc. - President, CEO & Director

Yes. Thanks, Sean, and thanks for having

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot